Please login to the form below

Not currently logged in
Email:
Password:

DiCE Molecules

This page shows the latest DiCE Molecules news and features for those working in and with pharma, biotech and healthcare.

Sanofi bets on DiCE to find oral alternatives to injectable drugs

Sanofi bets on DiCE to find oral alternatives to injectable drugs

Sanofi has made a small-molecule discovery engine developed by US biotech DiCE Molecules a core part of its R&D portfolio. ... DiCE's approach to drug discovery focuses on targeting protein-protein interactions that to date have only been addressed with

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2016 Deal Watch March 2016

    Acquisition – division. $5, 869. DiCE Molecules/ Sanofi. Technology platform to select and optimise drug-like ligands targeting a range of therapeutic areas. ... Acquisition of royalty rights. $1, 140. Blueprint Medicines/ Roche. Small molecules

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....